Drug shortages disrupt care at leading US cancer centers

All 31 leading cancer centers responding to a new survey reported shortages of at least one cancer drug, and nearly two-thirds said they resorted to mitigation strategies to keep patients on their recommended treatments. But in many cases, those mitigation strategies weren’t enough. Ninety percent of centers reported that treatment plans had to be modified because of drug shortages, creating additional insurance hurdles that may have delayed care.